Publications by authors named "David Marks"

Claim this Profile
O
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary.
Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, David I Marks

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.
Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr, Min Chen, Michael J Martens, David I Marks

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation of preventing vs. suppressing HPAI outbreaks: A case study from Iowa.
Peter Koppes, Travis Guerrant, David Marks, Eric Balcerzak, Jill Brown

Prev Vet Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Cost Burden of School Screening for Adolescent Idiopathic Scoliosis: A Systematic Review and Meta-Analysis.
Chuck Lam, Halil Bulut, Conor T Boylan, Jennifer Tasong, Kate Dobson, David Marks

Spine (Phila Pa 1976)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells.
Brooke R Tader, Luciana L Almada, Murat Toruner, Kayla C LaRue-Nolan, David L Marks

J Biol Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-centre early experience of the Pulse™ navigation system for posterior spinal fusion in adolescent idiopathic scoliosis (AIS).
Adam P Lloyd, Haiming Jin, George McKay, Mathew Sewell, Jwalant Mehta, David S Marks

Spine Deform· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer.
Luis F Flores, David L Marks, Renzo E Vera, Ashley N Sigafoos, Ezequiel J Tolosa

JCI Insight· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stronger Short-Term Memory, Larger Hippocampi and Area V1 in People with High VVIQ Scores.
David F Marks

Vision (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to Special Issue: Visual Mental Imagery System: How We Image the World.
David F Marks

Vision (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Writing a Medical Memoir: Lessons From a Long, Steep Road.
David I Marks

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.
Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, David I Marks

Am J Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A Podcast.
Marcos de Lima, David I Marks

Target Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of boundary conditions and blood rheology on indices of wall shear stress from IVUS-based patient-specific stented coronary artery simulations.
R Patrick McCarthy, Peter J Mason, David S Marks, John F LaDisa

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary.
David I Marks, Ryan D Cassaday, Josep-Maria Ribera, Andre C Schuh, Jae H Park

Expert Rev Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear Galectin-1 promotes -dependent activation of pancreatic cancer stellate cells.
Judith Vinaixa, Neus Martínez-Bosch, Joan Gibert, Noemí Manero-Rupérez, Patricia Santofimia-Castaño, David L Marks

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review.
David I Marks, Ryan D Cassaday, Josep-Maria Ribera, Andre C Schuh, Jae H Park

Expert Rev Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.
Giovanna Lucchini, Elena Cozma, Aimee Jackson, Kimberly Gilmour, Rachel Protheroe, David I Marks

Leuk Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior treatment on CAR T-cell outcome in adult ALL.
David I Marks, Anna Z Castleton

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.
Hagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, Marlise R Luskin, Matthias Stelljes, David I Marks

Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation.
Karen Ballen, Tao Wang, Naya He, Jennifer M Knight, Sanghee Hong, David I Marks

Transplant Cell Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
Ashley N Sigafoos, Ezequiel J Tolosa, Ryan M Carr, Maite G Fernandez-Barrena, Luciana L Almada, David L Marks

Cancer Res Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia.
Bela Patel, Amy A Kirkwood, Clare J Rowntree, Krisztina Z Alapi, Emilio Barretta, David I Marks

Hemasphere· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.
Avijeet Kumar Mishra, Saskia Burridge, Macarena Oporto Espuelas, Maeve O'Reilly, Michelle Cummins, David I Marks

Br J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, Denise Bonney, Kelly Watts, David I Marks

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis